IL6 and neoplasm: Furthermore, IL-6 secretion by certain stromal components (cancer-associated fibroblasts, macrophages, and neutrophils) drives EMT in associated tumor populations, which is supported by immunohistochemical staining at the invasive edge of patient breast tumors, where levels of phosphorylated STAT3 and IL-6 is elevated [93,94].